Skip to main content

Advertisement

SpringerLink
Log in

Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Ghrelin is a gastric hormone that posses multiple functions, including induction of growth hormone release, regulation of proinflammatory cytokines and control of food intake and energy homeostasis. A few reports on serum ghrelin level in chronic inflammatory states revealed contradictory results. The study was undertaken to determine ghrelin in patients with rheumatoid arthritis receiving infliximab, a TNF-α blocking agent. Serum ghrelin was determined in 18 female rheumatoid patients before the treatment with infliximab, 1 week after the first infusion and after 53 weeks of medication and compared with 15 age-matched healthy women. Serum ghrelin level was shown to be increased in the patients. A decrease in serum ghrelin level was found after the first infusion of infliximab and similarly decreased ghrelin level but still higher than in the control was shown in the 53rd week of medication. The obtained results suggest that ghrelin level is related to inflammation, and its serum level in patients with severe rheumatoid arthritis behaves similarly to acute-phase reactants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660

    Article  CAS  Google Scholar 

  2. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF et al (2000) Preliminary evidence that ghrelin, the natural GH secretagogue-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23:493–495

    Article  CAS  Google Scholar 

  3. Gualilo O, Lago F, Gómez-Reino J, Casanueva FF, Dieguez C (2003) Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett 552:105–109

    Article  Google Scholar 

  4. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M (2000) Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275:477–480

    Article  CAS  Google Scholar 

  5. Nakazato M, Murkami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194–198

    Article  CAS  Google Scholar 

  6. Nagaya N, Vematsu M, Kojima M (2001) Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationship between ghrelin and anabolic/catabolic factors. Circulation 104:2034–2038

    Article  CAS  Google Scholar 

  7. Yilmaz E, Ustundag B, Sen Y, Akarsu S, Kurt ANC, Dogan Y (2007) The level of ghrelin, TNF-α, and IL-6 in children with cyanotic and acyanotic congenital heart disease. Mediators Inflamm 2007:32403

    Article  Google Scholar 

  8. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908–913

    Article  CAS  Google Scholar 

  9. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K et al (2001) Ghrelin, an endogenous growth hormone secretagogoue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227–232

    Article  CAS  Google Scholar 

  10. Wu R, Dong W, Cui X, Zhon M, Simms HH, Ravikumart TS, Wang P (2007) Ghrelin down-regulates proinflammatory cytokines in sepsic through activation of the vagus nerve. Ann Surg 245:480–486

    Article  Google Scholar 

  11. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll L et al (2004) Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation 109:2221–2226

    Article  CAS  Google Scholar 

  12. Furst DE, Keystone EC, Kirkham B, Kavanaugh A, Fleischmann R, Mease P et al (2008) Updated consensus statement on biological agents for the treatment of rheumatic disease 2008. Ann Rheum Dis 67(suppl 3):iii2–iii25

    Article  CAS  Google Scholar 

  13. Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2004) Chronic inflammation modulates ghrelin levels in human and rats. Rheumatology 43:306–310

    Article  CAS  Google Scholar 

  14. Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Gonzalez-Juanatey C, de Matias JM et al (2008) Anti-tumor necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 67:1644–1646

    Article  CAS  Google Scholar 

  15. Maruna P, Gürlich R, Rosická M (2008) Ghrelin as an acute-phase reactant during postoperative stress response. Hum Metab Res 40:404–409

    Article  CAS  Google Scholar 

  16. Kümpers P, Horm R, Brabant G, Woywodt A, Schiffer M, Haller H, Haubitz M (2008) Serum lepitn and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology 47:484–487

    Article  Google Scholar 

  17. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R et al (2004) Ghrelin inhibit leptin—and activation-induced proinflammatory cytokines expression by human monocytes and T-cells. J Clin Invest 114:57–66

    Article  CAS  Google Scholar 

Download references

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Author information

Authors and Affiliations

  1. Medical University of Silesia, Katowice, Poland

    Michal Magiera, Magdalena Kopec-Medrek, Małgorzata Widuchowska, Anna Kotulska, Tomasz Dziewit, Damian Ziaja, Eugene J. Kucharz, Beata Logiewa-Bazger & Wlodzimierz Mazur

Authors
  1. Michal Magiera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena Kopec-Medrek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Małgorzata Widuchowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Kotulska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomasz Dziewit
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Damian Ziaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eugene J. Kucharz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Beata Logiewa-Bazger
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wlodzimierz Mazur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magdalena Kopec-Medrek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magiera, M., Kopec-Medrek, M., Widuchowska, M. et al. Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab. Rheumatol Int 33, 1611–1613 (2013). https://doi.org/10.1007/s00296-011-2262-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2262-7

Keywords

Search

Navigation